INOVIO to Present at Oppenheimer's 32nd Annual Healthcare Conference

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious...

Related Keywords

Ben Matone ,Jeff Richardson ,Kaneka Eurogentec ,J Joseph Kim ,Walter Reed Army Institute Of Research ,National Cancer Institute ,National Institute Of Allergy ,Plumbline Life Sciences ,Melinda Gates Foundation ,Coalition For Epidemic Preparedness Innovations ,Astrazeneca ,Defense Consortium ,Parker Institute For Cancer Immunotherapy ,International Vaccine Institute ,National Institutes Of Health ,Nuclear Defense Department Of ,Apollobio Corporation ,Vaccines Trial Network ,University Of Pennsylvania ,Wistar Institute ,Annual Healthcare Conference ,Annual Healthcare ,Relations Events ,Epidemic Preparedness Innovations ,Defense Advanced Research Projects ,Joint Program Executive Office ,Trial Network ,National Institutes ,National Institute ,Infectious Diseases ,Ology Bioservices ,Parker Institute ,Richter Helm Biologics ,Thermo Fisher Scientific ,Walter Reed Army Institute ,Inovio Pharmaceuticals ,Nc ,